HbA1c Variability and Adverse Outcomes in Patients Treated for Atrial Fibrillation: Beyond Glycemic Control?

Autor: Salle L; Department of Diabetology and Endocrinology, Dupuytren-2 University Hospital Center, Limoges, France.; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France., Guerra F; Cardiology and Arrhythmology Clinic, Marche University Hospital, Ancona, Italy.; Department of Biomedical Sciences and Public Health, Marche Polytechnic University of Ancona, Ancona, Italy.; Italian National Research Center on Aging, IRCCS INRCA, Ancona, Italy.
Jazyk: angličtina
Zdroj: European journal of preventive cardiology [Eur J Prev Cardiol] 2024 Aug 30. Date of Electronic Publication: 2024 Aug 30.
DOI: 10.1093/eurjpc/zwae285
Databáze: MEDLINE